- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Abbott Laboratories
Add to PortfolioABT:US
62.2500 USD 0.1700 0.27%As of 20:04:05 ET on 05/25/2012.
Snapshot for Abbott Laboratories (ABT)
| Open: | 62.1700 | Day's Range: | 62.1100 - 62.8500 | Volume: | 4,792,052 | Bid: | 62.2400 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 62.4200 | 52wk Range: | 46.2900 - 63.2000 | 1-Yr Rtn: | +25.10% | Ask: | 62.2500 |
Key Statistics for ABT
| Current P/E Ratio (ttm) | 12.8086 |
|---|---|
| Estimated P/E (12/2012) | 12.3414 |
| Earnings Per Share (USD) (ttm) | 4.8600 |
| Est. EPS (USD) (12/2012) | 5.0440 |
| Est. PEG Ratio | 1.2268 |
| Market Cap (M USD) | 97,943.62 |
| Shares Outstanding (M) | 1,573.39 |
| Enterprise Value (M USD) (ttm) | 105,153.74 |
| Enterprise Value/EBITDA (ttm) | 10.45 |
| Price/Book (mrq) | 3.8479 |
| Price/Sale (ttm) | 2.4837 |
| Dividend Indicated Gross Yield | 3.2771 |
| Next Earnings Announcement | 07/20/2012 |
More ABT Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ABT
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for ABT
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
| Miles D WhiteChairman/CEO | Laura J SchumacherExec VP/Secy/Gen Counsel |
| Thomas C FreymanExec VP:Finance/CFO | John C LandgrafExec VP:Nutritional Products |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page